Literature DB >> 16634032

Early-onset familial parkinsonism due to POLG mutations.

Guido Davidzon1, Paul Greene, Michelangelo Mancuso, Kevin J Klos, J Eric Ahlskog, Michio Hirano, Salvatore DiMauro.   

Abstract

OBJECTIVE: To define the molecular etiology of early-onset parkinsonism and peripheral neuropathy.
METHODS: Two sisters had early-onset parkinsonism (dystonic toe curling, action tremor, masked face, bradykinesia, stooped posture, and rigidity), together with clinical and electrophysiological signs of sensorimotor axonal peripheral neuropathy.
RESULTS: No mutations were found in the genes for parkin or PINK1. Muscle biopsies showed ragged-red and cytochrome c oxidase-negative fibers, and biochemistry showed decreased activities of respiratory chain complexes containing mitochondrial DNA-encoded subunits. Multiple mitochondrial DNA deletions were seen by long polymerase chain reaction, and sequencing of the POLG gene showed that the patients were compound heterozygous for two patogenic mutations.
INTERPRETATION: POLG mutations can cause early-onset parkinsonism in the absence of progressive external ophthalmoplegia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16634032     DOI: 10.1002/ana.20831

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  79 in total

Review 1.  Mitochondrial DNA replication and disease: insights from DNA polymerase γ mutations.

Authors:  Jeffrey D Stumpf; William C Copeland
Journal:  Cell Mol Life Sci       Date:  2010-10-08       Impact factor: 9.261

2.  Reduced stimulation of recombinant DNA polymerase γ and mitochondrial DNA (mtDNA) helicase by variants of mitochondrial single-stranded DNA-binding protein (mtSSB) correlates with defects in mtDNA replication in animal cells.

Authors:  Marcos T Oliveira; Laurie S Kaguni
Journal:  J Biol Chem       Date:  2011-09-26       Impact factor: 5.157

3.  The DNA polymerase gamma Y955C disease variant associated with PEO and parkinsonism mediates the incorporation and translesion synthesis opposite 7,8-dihydro-8-oxo-2'-deoxyguanosine.

Authors:  Maria A Graziewicz; Rachelle J Bienstock; William C Copeland
Journal:  Hum Mol Genet       Date:  2007-08-27       Impact factor: 6.150

4.  Disease mutations in the human mitochondrial DNA polymerase thumb subdomain impart severe defects in mitochondrial DNA replication.

Authors:  Rajesh Kasiviswanathan; Matthew J Longley; Sherine S L Chan; William C Copeland
Journal:  J Biol Chem       Date:  2009-05-28       Impact factor: 5.157

Review 5.  Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.

Authors:  Rebecca Banerjee; Anatoly A Starkov; M Flint Beal; Bobby Thomas
Journal:  Biochim Biophys Acta       Date:  2008-11-14

6.  Variations of mitochondrial DNA polymerase γ in patients with Parkinson's disease.

Authors:  S Ylönen; P Ylikotila; A Siitonen; S Finnilä; J Autere; K Majamaa
Journal:  J Neurol       Date:  2013-12       Impact factor: 4.849

7.  MANF improves the MPP+/MPTP-induced Parkinson's disease via improvement of mitochondrial function and inhibition of oxidative stress.

Authors:  Yigang Liu; Jingxing Zhang; Ming Jiang; Qiong Cai; Jianmin Fang; Lingjing Jin
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

Review 8.  Movement disorders in mitochondrial disease.

Authors:  Roula Ghaoui; Carolyn M Sue
Journal:  J Neurol       Date:  2018-01-06       Impact factor: 4.849

9.  Mitochondrial DNA haplogroups and subhaplogroups are associated with Parkinson's disease risk in a Polish PD cohort.

Authors:  Katarzyna Gaweda-Walerych; Aleksandra Maruszak; Krzysztof Safranow; Monika Bialecka; Gabriela Klodowska-Duda; Krzysztof Czyzewski; Jaroslaw Slawek; Monika Rudzinska; Maria Styczynska; Grzegorz Opala; Marek Drozdzik; Jeffrey A Canter; Maria Barcikowska; Cezary Zekanowski
Journal:  J Neural Transm (Vienna)       Date:  2008-09-23       Impact factor: 3.575

Review 10.  Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism.

Authors:  David N Hauser; Teresa G Hastings
Journal:  Neurobiol Dis       Date:  2012-10-12       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.